No video

APHINITY Trial for HER2+ Breast Cancer

  Рет қаралды 105

Targeted Oncology

Targeted Oncology

Күн бұрын

Ruth O’Regan, MD, describes the clinical importance of the APHINITY trial in treating HER2-positive breast cancer and the unmet needs in this patient population.
For more resources and information regarding anticancer targeted therapies: targetedonc.com/

Пікірлер
APHINITY Trial in HER2+ Breast Cancer
7:30
OncLive
Рет қаралды 1,4 М.
لااا! هذه البرتقالة مزعجة جدًا #قصير
00:15
One More Arabic
Рет қаралды 52 МЛН
WHO CAN RUN FASTER?
00:23
Zhong
Рет қаралды 43 МЛН
天使救了路飞!#天使#小丑#路飞#家庭
00:35
家庭搞笑日记
Рет қаралды 89 МЛН
59-Year-Old Man With Relapsed Follicular Lymphoma
5:18
Targeted Oncology
Рет қаралды 1 М.
CLEOPATRA: pertuzumab, trastuzumab & chemo for HER2+ mBC
2:40
VJOncology
Рет қаралды 3,3 М.
My NEET PG Result - Did YouTube Destroy My Rank?! Dr. Anuj Pachhel
16:11
Warning signs of testicular cancer
4:25
13WHAM ABC News
Рет қаралды 86 М.
Signs of sudden cardiac arrest could show up early
3:16
CBS Mornings
Рет қаралды 166 М.
Turning Stem Cell Biology into Stem Cell Medicine
11:01
University of Rochester
Рет қаралды 1 М.
Langstein on Implants and Cancer Risk.flv
3:12
UR Medicine
Рет қаралды 1,2 М.
لااا! هذه البرتقالة مزعجة جدًا #قصير
00:15
One More Arabic
Рет қаралды 52 МЛН